CSIMarket
 
Talaris Therapeutics Inc   (TALS)
 

The arising business from the Biotechnology & Pharmaceuticals industry the Talaris Therapeutics Inc released the most recent fiscal period, earnings

TALS delivered fourth quarter of 2022 operating shortfall of $-19.825 millions


Published Apr 02 2023
Goran Soko / CSIMarket.com Contributer


Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons While the earnings season of the October to December 31 2022 goes on, the most companies have declared the respective numbers. In the thick of it, are several constituents of the Biotechnology & Pharmaceuticals industry. As well as, today, Talaris Therapeutics Inc disclosed operating deficit of $-19.825 millions, for the October to December 31 2022 span.

The brilliant approach to frame the most recent fiscal period result, in the current stage of the business. It is straight forward to compare the operating deficit of the fourth quarter of 2021, which has been $-14.388 millions.


Not alarmingly the small business reported a net loss of $-18.528 millions, which has expanded from $-14.241 millions, in the corresponding span a previous year.

TALS announced deficit of $-73.89 millions and Revenues of $0.00 millions in the financial period 2022.

Net deficit per share has widen to $-1.79 from $-1.64 in previous financial year, while by 0 % from $0.00 millions a year prior.

Talaris Therapeutics Inc is expected to report next financial earnings on May 11, 2023.



Talaris Therapeutics Inc's Revenue Growth

Talaris Therapeutics Inc's Operating Margin



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071